⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 27, 2024Open Access

Rapid Emergence of Resistance to Broad-Spectrum Direct Antimicrobial Activity of Avibactam

Michelle Nägeli Shade Rodriguez Abigail L. Manson Ashlee M. Earl Thea Brennan-Krohn

View Full Paper

Ask AI

Bookmark

Share

Abstract

Avibactam (AVI) is a diazabicyclooctane (DBO) β-lactamase inhibitor used clinically in combination with ceftazidime. At concentrations higher than those typically achieved

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nägeli et al. (2024) studied this question.

synapsesocial.com/papers/68e572c8b6db643587513126 https://doi.org/10.1101/2024.09.25.615047

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Molecular mechanisms underlying bacterial resistance to ceftazidime/avibactamReview · 2022 · 44 citations
2Aztreonam–Avibactam (Emblaveo®) for Carbapenem-Resistant and Metallo-β-Lactamase-Producing Gram-Negative Infections: A Comprehensive ReviewLate-Phase Clinical Trial · 2026
3Ceftazidime-avibactam resistance evolution in <i>Pseudomonas aeruginosa</i> and implications for cross-resistance to other novel β-lactamsOriginal Research · 2026 · 4 citations
4P-1319. Antimicrobial Activity of Aztreonam-Avibactam and Molecular Characterization of Enterobacterales Resistant to Ceftazidime-Avibactam and/or Meropenem-Vaborbactam from United States Medical Centers (2016-2024)Original Research · 2026
5Dilution susceptibility testing method evaluation for the combination of ceftibuten and avibactam against Enterobacterales2025

More related papers

IN VITRO SUSCEPTIBILITY COMPARISON OF AZTREONAM ALONG WITH CEFTAZIDIME-AVIBACTAM SYNERGY TESTING METHODS AND AZTREONAMAVIBACTAM AGAINST CARBAPENEM RESISTANT ORGANISMS IN ISOLATES OBTAINED FROM CANCER PATIENTS2025
Drug utilization evaluation of ceftazidime-avibactam in a tertiary care hospital2024
P-1335. The in vitro activities of aztreonam-avibactam and cefiderocol against metallo-β-lactamase-producing Enterobacterales isolates collected as a part of the ATLAS Global Surveillance Program, 2021-20222026